Rachel Bartash
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antifungal resistance and susceptibility
Papers in
-
- COVID-19 Clinical Research Studies 5
- Clostridium difficile and Clostridium perfringens research 4
- Oncology 7
- Neutropenia and Cancer Infections 4
- Polyomavirus and related diseases 2
- Co-authors
- Enver Akalin (2 shared papers)Yorg Azzi (2 shared papers)P. del Valle Loarte (2 shared papers)Joseph R. Scalea (1 shared paper)Priya Nori (11 shared papers)Kelsie Cowman (11 shared papers)Wendy Szymczak (8 shared papers)Yi Guo (7 shared papers)
- Journals
- Open Forum Infectious Diseases (7 papers)JCO Oncology Practice (1 paper)International Journal of Infectious Diseases (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)Lung (1 paper)
- Partner nations
- United StatesCanadaUganda
In The Last Decade
Rachel Bartash
24 papers receiving 686 citations
Peers
Comparison fields: 5 of 92
- Applied Microbiology and Biotechnology 135
- Infectious Diseases 331
- Transplantation 22
- Molecular Medicine 44
- Obstetrics and Gynecology 57
Countries citing papers authored by Rachel Bartash
This map shows the geographic impact of Rachel Bartash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Bartash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Bartash more than expected).
Fields of papers citing papers by Rachel Bartash
This network shows the impact of papers produced by Rachel Bartash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Bartash. The network helps show where Rachel Bartash may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel Bartash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 211 | |
| 2 | 2020 | 198 | |
| 3 | 2020 | 90 | |
| 4 | 2003 | 58 | |
| 5 | 2017 | 28 | |
| 6 | 2019 | 23 | |
| 7 | 2020 | 22 | |
| 8 | 2017 | 16 | |
| 9 | 2020 | 11 | |
| 10 | 2022 | 9 | |
| 11 | 2020 | 5 | |
| 12 | 2021 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2019 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2019 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2021 | 2 |
About Rachel Bartash
Rachel Bartash is a scholar working on Infectious Diseases, Oncology, Epidemiology, Applied Microbiology and Biotechnology and Surgery, having authored 27 papers that have together received 699 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Antibiotic Use and Resistance (4 papers), Neutropenia and Cancer Infections (4 papers), Antibiotic Resistance in Bacteria (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Polyomavirus and related diseases (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (135 citations), Infectious Diseases (331 citations), Transplantation (22 citations), Molecular Medicine (44 citations) and Obstetrics and Gynecology (57 citations). Rachel Bartash has collaborated with scholars based in United States, Canada and Uganda. Frequent co-authors include Enver Akalin, Yorg Azzi, P. del Valle Loarte, Joseph R. Scalea, Priya Nori, Kelsie Cowman, Wendy Szymczak, Yi Guo, Victor Chen and Philip Gialanella. Their work appears in journals such as Open Forum Infectious Diseases, JCO Oncology Practice, International Journal of Infectious Diseases, Diagnostic Microbiology and Infectious Disease and Lung.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.